Steven Frank Receives Stock Award at Biocryst Pharmaceuticals Inc (BCRX) — SEC Form 4, Jun 16, 2025

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Steven Frank

Director

TXN 2025-06-12 · FILED 2025-06-16

Equity Position 14.7K sh 2,199 → 14,699

Equity Change +568.4% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Biocryst Pharmaceuticals Inc

BCRX CIK 0000882796

Reporting Owner

Name	Relationship
Steven Frank CIK 0001583886	Director

Steven Frank at Biocryst Pharmaceuticals Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Biocryst Pharmaceuticals Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2025-06-12	A - Award/Grant	12,500 A	$0.00	—	14,699	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Automatic Stock Option GrantF2	$10.40	2025-06-12	A - Award/Grant	27,181 A	$0.00	2035-06-12	27,181 Common Stock	Direct

Footnotes (2)

F1: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. Show more
F2: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Biocryst Pharmaceuticals Inc

GET /v1/forms/4/0001171843-25-003911 API docs